Little Green Pharma has launched its first dried flower cannabis medicine to help meet increasing patient demand and plug the flower shortage.

LGP’s flower product complements its range of cannabis oils

LGP Flower THC 22 – Desert Flame is a Schedule 8 medicine with 22% THC and less than 1% CBD. The product is available in a 15g container and is expected to be prescribed via inhalation using a vaporiser. It complements LGP’s existing medicinal cannabis oil product range.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Leave a comment